Omeros | OMER - Текущие обязательства





Текущие обязательства Изменить Дата
Adma Biologics USD 95.28M 19.52M 2026-09
Alnylam Pharmaceuticals USD 2.06B 550.49M 2026-09
BioMarin Pharmaceutical USD 1.6B 59.17M 2026-09
Cytokinetics USD 353.42M 171.99M 2026-09
Gilead Sciences USD 12B 982M 2026-09
Heron Therapeutics USD 92.14M 1.63M 2026-06
Immunic USD 38.36M 7.74M 2026-03
Insmed USD 596.57M 157.83M 2026-09
Knight Therapeutics CAD 165.26M 12.58M 2025-12
MacroGenics USD 108.82M 12.88M 2026-06
Omeros USD 85.5M 2.28M 2025-06
Pacira USD 122.01M 13.22M 2026-06
Pfizer USD 31.73B 920M 2026-09
Rockwell Medical USD 10.95M 259K 2025-06
Sangamo BioSciences USD 47.66M 1.9M 2025-06
Sarepta Therapeutics USD 502.91M 3.74M 2026-06
United Therapeutics USD 624.3M 16.5M 2026-09
Vertex Pharmaceuticals USD 5B 1.06B 2026-09